| PR Title: |
ONET TECHNOLOGIES teams up with ALGETA for ALPHARADIN commercialization |
| PR Summary: |
ONET TECHNOLOGIES UK Ltd (OTUK) has agreed to manufacture specialised hot cells for the production and commercialization of ALPHARADIN (radium-223 chloride). Developed by ALGETA SAS of Norway, ALPHARADIN is a highly targeted alpha-pharmaceutical, currently under clinical evaluation, which is intended to improve survival in patients with bone metastases from advanced cancer. |